Literature DB >> 22359709

Susceptibilities of common bacterial isolates from oman to old and new antibiotics.

Mubarak Al-Yaqoubi1, Kamal Elhag.   

Abstract

OBJECTIVES: The purpose of this study is to compare the antimicrobial activity of linezolid and tigecycline with other commonly used antibiotics against a variety of clinical isolates at Royal Hospital, Muscat.
METHODS: Clinically-significant bacterial isolates in Royal hospital during the period from 1st of March to 30th of June 2007 were collected, stored and finally tested to determine their susceptibility to different antibiotics by broth microdilution (microscan panels).
RESULTS: Two hundred ten bacterial strains were collected and tested including Staphylococcus aureus (29), Group B ß-haemolytic Streptococcus (10), Streptococcus pneumoniae (15), Enterococcus spp. (16), Haemophilus spp. (15), Escherichia coli (26), Klebsiella spp. (26), Enterobacter spp. (25), Serratia spp. (10), Acinetobacter baumannii (17) and Pseudomonas aeruginosa (21). All strains except P. aeuginosa were susceptible to tigecycline. All gram-positive strains were susceptible to linezolid. Meropenem and piperacillin-tazobactam showed good activity against most organisms tested including P. aeruginosa and Acinetobacter baumannii. Levofloxacin showed 100% activity against K. pneumoniae and 61% activity against E. coli. The activity of 3rd generation cephalosporins against E.coli and K.pneumoniae ranged from 76% to 100%.
CONCLUSION: Tigecycline and linezolid showed excellent activity against microorganisms in their relevant spectrum of activity. However, they should be used wisely and judiciously.

Entities:  

Year:  2008        PMID: 22359709      PMCID: PMC3282317     

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  24 in total

Review 1.  Surveillance of antibiotic resistance in European ICUs.

Authors:  H Hanberger; D Diekema; A Fluit; R Jones; M Struelens; R Spencer; M Wolff
Journal:  J Hosp Infect       Date:  2001-07       Impact factor: 3.926

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 3.  OXA-type carbapenemases.

Authors:  Jan Walther-Rasmussen; Niels Høiby
Journal:  J Antimicrob Chemother       Date:  2006-01-30       Impact factor: 5.790

Review 4.  Tigecycline: a new glycylcycline antimicrobial agent.

Authors:  Nishaminy Kasbekar
Journal:  Am J Health Syst Pharm       Date:  2006-07-01       Impact factor: 2.637

Review 5.  Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.

Authors:  Michael A Pfaller; John Segreti
Journal:  Clin Infect Dis       Date:  2006-04-15       Impact factor: 9.079

Review 6.  Two decades of imipenem therapy.

Authors:  A C Rodloff; E J C Goldstein; A Torres
Journal:  J Antimicrob Chemother       Date:  2006-09-22       Impact factor: 5.790

7.  Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs.

Authors:  Hesna Yigit; Gregory J Anderson; James W Biddle; Christine D Steward; J Kamile Rasheed; Lourdes L Valera; John E McGowan; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

8.  Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.

Authors:  D L Paterson; L Mulazimoglu; J M Casellas; W C Ko; H Goossens; A Von Gottberg; S Mohapatra; G M Trenholme; K P Klugman; J G McCormack; V L Yu
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

9.  Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.

Authors:  Charles R Dean; Melissa A Visalli; Steven J Projan; Phaik-Eng Sum; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

10.  Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital.

Authors:  Laurent Poirel; Olivier Menuteau; Nathalie Agoli; Christian Cattoen; Patrice Nordmann
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

View more
  3 in total

1.  VanA and VanB Positive Vancomycin-resistant Staphylococcus aureus Among Clinical Isolates in Shiraz, South of Iran.

Authors:  Sareh Saadat; Kavous Solhjoo; Mohammad-Javad Norooz-Nejad; Akbar Kazemi
Journal:  Oman Med J       Date:  2014-09

2.  Prevalence of Extended-spectrum β-Lactamases-producing Escherichia coli from Hospitals in Khartoum State, Sudan.

Authors:  Mutasim E Ibrahim; Naser E Bilal; Magzoub A Magzoub; Mohamed E Hamid
Journal:  Oman Med J       Date:  2013-03

Review 3.  β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.

Authors:  Hosam M Zowawi; Hanan H Balkhy; Timothy R Walsh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.